Marketing-authorisation holder · Austria
Amomed Pharma Gmbh
12 medicines in 5 countries, as authorisation holder.
Group structure
Part of
AmomedPharmaceutical groupOther companies in the group
Austria1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Esmocard 10 mg/ml otopina za injekcijuotopina za injekciju | Esmolol | Croatia | Marketed | 2017 |
| LANDIOBLOCConcentrato per soluzione iniettabile | Landiolol | Italy | Authorised | |
| Rapibloc 20 mg/2 ml concentraat voor oplossing voor injectieConcentraat voor oplossing voor injectie | Landiolol | Netherlands | Authorised | 2016 |
| Rapibloc 20 mg/2 ml koncentrat za otopinu za injekcijukoncentrat za otopinu za injekciju | Landiolol | Croatia | Not marketed | 2021 |
| Rapibloc 300 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Landiolol | Netherlands | Authorised | 2016 |
| Rapibloc 300 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju | Landiolol | Croatia | Marketed | 2021 |
| TRESUVI 1 MG/ML SOLUCION PARA PERFUSION EFG1,0 mg · Solución para perfusión | Treprostinil | Spain | Marketed | 2020 |
| TRESUVI 10 MG/ML SOLUCION PARA PERFUSION EFG10,0 mg · Solución para perfusión | Treprostinil | Spain | Marketed | 2020 |
| TRESUVI 2,5 MG/ML SOLUCION PARA PERFUSION EFG2,5 mg · Solución para perfusión | Treprostinil | Spain | Marketed | 2020 |
| TRESUVI 5 MG/ML SOLUCION PARA PERFUSION EFG5,0 mg · Solución para perfusión | Treprostinil | Spain | Marketed | 2020 |
| NALTREXONA AMOMED 50 mg50mg · Compr. film. | Naltrexone | Romania | unknown | |
| NALTREXONA TORREX 50 mg50mg · Compr. film. | Naltrexone | Romania | unknown |